AMPKα Is Suppressed in Bladder Cancer through Macrophage-Mediated Mechanisms.

AMPKα Is Suppressed in Bladder Cancer through Macrophage-Mediated Mechanisms.
复制标题

DOI:
10.1016/j.tranon.2016.07.007
复制
发表时间:
2016-12
影响因子:
5
通讯作者:
Claffey, Kevin P.
Claffey, Kevin P.
中科院分区:
医学3区
文献类型:
--
作者:
Kopsiaftis, Stavros;Hegde, Poornima;Taylor, John A., III;Claffey, Kevin P.

文献摘要

参考文献

被引文献

相似文献

Bladder cancer presents as either low- or high-grade disease, each with distinct mutational profiles; however, both display prominent mTORC1 activation. One major negative regulator of mTORC1 is AMPK, which is a critical metabolic regulator that suppresses cellular growth in response to metabolic stress by negatively regulating mTORC1. Alterations in the activation and protein levels of AMPK have been reported in breast, gastric, and hepatocellular carcinoma. To investigate whether AMPK suppression is responsible for mTOR activation in bladder cancer, the levels of AMPKα were quantified in a cohort of primary human bladder cancers and adjacent nontumor tissues. The levels of p-AMPKα, AMPKα1, AMPKα2, and total AMPKα were significantly suppressed in both low- and high-grade disease when compared with nontumor tissue. To elucidate the AMPKα suppression mechanism, we focused on inflammation, particularly tumor-infiltrating macrophages, due to their reported role in regulating AMPK expression. Treatment of HTB2 cancer cells with varying doses of differentiated U937 macrophage conditioned medium (CM) demonstrated a dose-dependent reduction of AMPKα protein. Additionally, macrophage CM treatment of HTB2 and HT1376 bladder cells for various times also reduced AMPKα protein but not mRNA levels. Direct TNFα treatment also suppressed AMPKα at the protein but not RNA level. Finally, staining of the human cohort for CD68, a macrophage marker, revealed that CD68+ cell counts correlated with reduced AMPKα levels. In summary, these data demonstrate the potential role for inflammation and inflammatory cytokines in regulating the levels of AMPKα and promoting mTORC1 activation in bladder cancer.
DOI: 10.1016/j.bbrc.2009.05.106
发表时间: 2009-08-14
影响因子: 3.1
作者:
Nath, Narender;Khan, Musfiquidin;Rattan, Ramandeep;Mangalam, Ashutosh;Makkar, Randhir S.;de Meester, Carloe;Bertrand, Luc;Singh, Inderjit;Chen, Yingjie;Viollet, Benoit;Giri, Shailendra
通讯作者: Giri, Shailendra
DOI: 10.1007/s12272-015-0549-z
发表时间: 2015-03
影响因子: 6.7
作者:
Jeon SM;Hay N
通讯作者: Hay N
DOI: 10.1042/bst20130244
发表时间: 2014-03
影响因子: 3.9
作者:
Gowans GJ;Hardie DG
通讯作者: Hardie DG
DOI: 10.1158/0008-5472.can-11-3870
发表时间: 2012-05-15
期刊: Cancer research
影响因子: 11.2
作者:
Kim YH;Liang H;Liu X;Lee JS;Cho JY;Cheong JH;Kim H;Li M;Downey TJ;Dyer MD;Sun Y;Sun J;Beasley EM;Chung HC;Noh SH;Weinstein JN;Liu CG;Powis G
通讯作者: Powis G
营养应激通过抑制心脏中 AMP 激活的蛋白激酶来激活炎症并降低葡萄糖代谢。
DOI: 10.2337/db08-1361
发表时间: 2009-11
期刊: Diabetes
影响因子: 7.7
作者:
Ko HJ;Zhang Z;Jung DY;Jun JY;Ma Z;Jones KE;Chan SY;Kim JK
通讯作者: Kim JK